Thomas Woiwode, Director at Aligos Therapeutics, Inc. (ALGS), bought 663,959 shares at $15.00 ($3.0M) on 2020-10-20, disclosed to the SEC on 2020-10-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 463,959 | $0 | 0.0% |
| 2 | $15.00 | 200,000 | $3.0M | 100.0% |
| Total | $4.52 avg | 663,959 | $3.0M | 100% |
| Filing → |
| PASG | BUY | 2020-03-03 | $4.0M | — | Filing → |
| CRSP | SELL | 2018-05-17 | $2.6M | — | Filing → |
| CRSP | SELL | 2018-05-09 | $6.1M | — | Filing → |